Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

Moderna (MRNA) closed at $63.94 in the latest trading session, marking a -0.31% move from the prior day. This change lagged the S&P 500's 0.25% gain on the day. At the same time, the Dow added 0.2%, ...

Shares of Moderna Inc. MRNA dropped 0.31% to $63.94 Tuesday, on what proved to be an all-around favorable trading session for ...

The new Pfizer and Moderna mRNA vaccines against COVID were approved in August. Vaccinations are now widely available.

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...

The NHS is offering autumn Covid boosters to the most vulnerable in October. Many pharmacies also now sell the Covid jab ...

There's a new bulletin from Florida's surgeon general. Vaccine experts and historians interviewed for this article can’t ...

The government has already disbursed more than 900 million free at-home COVID-19 tests, and will be reopening its free test ...

The Biden administration is about to announce free coronavirus tests for Americans, ahead of what is expected to be an active respiratory virus season.

While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Carisma Therapeutics has gone public, entered a broad collaboration with Moderna, and ceased development of its original ...